Page last updated: 2024-09-03

ym 022 and ag-041r

ym 022 has been researched along with ag-041r in 2 studies

Compound Research Comparison

Studies
(ym 022)
Trials
(ym 022)
Recent Studies (post-2010)
(ym 022)
Studies
(ag-041r)
Trials
(ag-041r)
Recent Studies (post-2010) (ag-041r)
651827011

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Håkanson, R; Lindström, E; Monstein, HJ; Nilsson, I; Svensson, S1
Ding, XQ; Håkanson, R; Lindström, E; Norlén, P1

Reviews

1 review(s) available for ym 022 and ag-041r

ArticleYear
CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Regulatory peptides, 1999, Mar-17, Volume: 80, Issue:1-2

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Chromogranin A; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Hormone Antagonists; Humans; Indoles; Pancreatic Hormones; Parietal Cells, Gastric; Phenylurea Compounds; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stomach

1999

Other Studies

1 other study(ies) available for ym 022 and ag-041r

ArticleYear
Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
    Regulatory peptides, 2002, Jan-15, Volume: 103, Issue:1

    Topics: Animals; Binding Sites; Binding, Competitive; Cell Line; Cell Membrane; COS Cells; Gene Expression; Guanosine Triphosphate; Humans; Kinetics; Ligands; Models, Theoretical; Neuroblastoma; Radioligand Assay; Receptor, Cholecystokinin B; Receptors, Cell Surface; Receptors, Cholecystokinin; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured

2002